207 related articles for article (PubMed ID: 22634164)
1. Chronic administration of the selective P2X3, P2X2/3 receptor antagonist, A-317491, transiently attenuates cancer-induced bone pain in mice.
Hansen RR; Nasser A; Falk S; Baldvinsson SB; Ohlsson PH; Bahl JM; Jarvis MF; Ding M; Heegaard AM
Eur J Pharmacol; 2012 Aug; 688(1-3):27-34. PubMed ID: 22634164
[TBL] [Abstract][Full Text] [Related]
2. Endogenous opioid mechanisms partially mediate P2X3/P2X2/3-related antinociception in rat models of inflammatory and chemogenic pain but not neuropathic pain.
McGaraughty S; Honore P; Wismer CT; Mikusa J; Zhu CZ; McDonald HA; Bianchi B; Faltynek CR; Jarvis MF
Br J Pharmacol; 2005 Sep; 146(2):180-8. PubMed ID: 16041397
[TBL] [Abstract][Full Text] [Related]
3. Effects of A-317491, a novel and selective P2X3/P2X2/3 receptor antagonist, on neuropathic, inflammatory and chemogenic nociception following intrathecal and intraplantar administration.
McGaraughty S; Wismer CT; Zhu CZ; Mikusa J; Honore P; Chu KL; Lee CH; Faltynek CR; Jarvis MF
Br J Pharmacol; 2003 Dec; 140(8):1381-8. PubMed ID: 14623769
[TBL] [Abstract][Full Text] [Related]
4. Spontaneous firing and evoked responses of spinal nociceptive neurons are attenuated by blockade of P2X3 and P2X2/3 receptors in inflamed rats.
Xu J; Chu KL; Brederson JD; Jarvis MF; McGaraughty S
J Neurosci Res; 2012 Aug; 90(8):1597-606. PubMed ID: 22422599
[TBL] [Abstract][Full Text] [Related]
5. P2X3 and P2X2/3 receptors mediate mechanical hyperalgesia induced by bradykinin, but not by pro-inflammatory cytokines, PGE₂ or dopamine.
de Oliveira Fusaro MC; Pelegrini-da-Silva A; Araldi D; Parada CA; Tambeli CH
Eur J Pharmacol; 2010 Dec; 649(1-3):177-82. PubMed ID: 20868656
[TBL] [Abstract][Full Text] [Related]
6. Functional up-regulation of P2X3 receptors in dorsal root ganglion in a rat model of bone cancer pain.
Wu JX; Xu MY; Miao XR; Lu ZJ; Yuan XM; Li XQ; Yu WF
Eur J Pain; 2012 Nov; 16(10):1378-88. PubMed ID: 22528605
[TBL] [Abstract][Full Text] [Related]
7. P2X3 and P2X2/3 receptors activation induces articular hyperalgesia by an indirect sensitization of the primary afferent nociceptor in the rats' knee joint.
Teixeira JM; Parada CA; Tambeli CH
Eur J Pharmacol; 2020 Jul; 879():173054. PubMed ID: 32145326
[TBL] [Abstract][Full Text] [Related]
8. A-317491, a selective P2X3/P2X2/3 receptor antagonist, reverses inflammatory mechanical hyperalgesia through action at peripheral receptors in rats.
Wu G; Whiteside GT; Lee G; Nolan S; Niosi M; Pearson MS; Ilyin VI
Eur J Pharmacol; 2004 Nov; 504(1-2):45-53. PubMed ID: 15507220
[TBL] [Abstract][Full Text] [Related]
9. Blockade and reversal of spinal morphine tolerance by P2X3 receptor antagonist.
Ma X; Xu T; Xu H; Jiang W
Behav Pharmacol; 2015 Apr; 26(3):260-7. PubMed ID: 25350728
[TBL] [Abstract][Full Text] [Related]
10. A-317491, a novel potent and selective non-nucleotide antagonist of P2X3 and P2X2/3 receptors, reduces chronic inflammatory and neuropathic pain in the rat.
Jarvis MF; Burgard EC; McGaraughty S; Honore P; Lynch K; Brennan TJ; Subieta A; Van Biesen T; Cartmell J; Bianchi B; Niforatos W; Kage K; Yu H; Mikusa J; Wismer CT; Zhu CZ; Chu K; Lee CH; Stewart AO; Polakowski J; Cox BF; Kowaluk E; Williams M; Sullivan J; Faltynek C
Proc Natl Acad Sci U S A; 2002 Dec; 99(26):17179-84. PubMed ID: 12482951
[TBL] [Abstract][Full Text] [Related]
11. Flexible subunit stoichiometry of functional human P2X2/3 heteromeric receptors.
Kowalski M; Hausmann R; Schmid J; Dopychai A; Stephan G; Tang Y; Schmalzing G; Illes P; Rubini P
Neuropharmacology; 2015 Dec; 99():115-30. PubMed ID: 26184350
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory role of supraspinal P2X3/P2X2/3 subtypes on nociception in rats.
Fukui M; Nakagawa T; Minami M; Satoh M; Kaneko S
Mol Pain; 2006 Jun; 2():19. PubMed ID: 16753051
[TBL] [Abstract][Full Text] [Related]
13. P2X2/3 and P2X3 receptors contribute to the metaboreceptor component of the exercise pressor reflex.
McCord JL; Tsuchimochi H; Kaufman MP
J Appl Physiol (1985); 2010 Nov; 109(5):1416-23. PubMed ID: 20798273
[TBL] [Abstract][Full Text] [Related]
14. Electroacupuncture and A-317491 depress the transmission of pain on primary afferent mediated by the P2X3 receptor in rats with chronic neuropathic pain states.
Wang WS; Tu WZ; Cheng RD; He R; Ruan LH; Zhang L; Gong YS; Fan XF; Hu J; Cheng B; Lai YP; Zou EM; Jiang SH
J Neurosci Res; 2014 Dec; 92(12):1703-13. PubMed ID: 25041872
[TBL] [Abstract][Full Text] [Related]
15. Antagonists to TRPV1, ASICs and P2X have a potential role to prevent the triggering of regional bone metabolic disorder and pain-like behavior in tail-suspended mice.
Hanaka M; Iba K; Dohke T; Kanaya K; Okazaki S; Yamashita T
Bone; 2018 May; 110():284-294. PubMed ID: 29452264
[TBL] [Abstract][Full Text] [Related]
16. Update on novel purinergic P2X3 and P2X2/3 receptor antagonists and their potential therapeutic applications.
Marucci G; Dal Ben D; Buccioni M; Martí Navia A; Spinaci A; Volpini R; Lambertucci C
Expert Opin Ther Pat; 2019 Dec; 29(12):943-963. PubMed ID: 31726893
[No Abstract] [Full Text] [Related]
17. Systemic blockade of P2X3 and P2X2/3 receptors attenuates bone cancer pain behaviour in rats.
Kaan TK; Yip PK; Patel S; Davies M; Marchand F; Cockayne DA; Nunn PA; Dickenson AH; Ford AP; Zhong Y; Malcangio M; McMahon SB
Brain; 2010 Sep; 133(9):2549-64. PubMed ID: 20802203
[TBL] [Abstract][Full Text] [Related]
18. [P2x3-receptor desensitization as an alternative mechanism of analgesia].
Petrenko NS; Kryshtal' OO
Fiziol Zh (1994); 2013; 59(2):104-10. PubMed ID: 23828978
[TBL] [Abstract][Full Text] [Related]
19. Antinociceptive properties of a non-nucleotide P2X3/P2X2/3 receptor antagonist.
McGaraughty S; Jarvis MF
Drug News Perspect; 2005 Oct; 18(8):501-7. PubMed ID: 16391720
[TBL] [Abstract][Full Text] [Related]
20. Effect of emodin on neuropathic pain transmission mediated by P2X2/3 receptor of primary sensory neurons.
Gao Y; Liu H; Deng L; Zhu G; Xu C; Li G; Liu S; Xie J; Liu J; Kong F; Wu R; Li G; Liang S
Brain Res Bull; 2011 Apr; 84(6):406-13. PubMed ID: 21303687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
